The US Department of Justice just released an updated guidance on its Evaluation of Corporate Compliance Programs replacing the previous release from February 2017. A General Counsel & Chief Compliance from the Pharma Industry quoted to Symfact:
The DOJ guidance on corporate compliance programs reads like a sales pitch for your TPR platform!
If you need a copy of the document, please send an email to [email protected]
